会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • Gamma-tocopherol therapy for restenosis prevention
    • 伽马生育酚治疗预防再狭窄
    • US20070014827A1
    • 2007-01-18
    • US10595453
    • 2004-10-21
    • James LarrickJames Peacock
    • James LarrickJames Peacock
    • A61F2/00
    • A61K48/005A61K31/355A61K45/06A61L31/16A61L2300/258A61L2300/416A61L2300/428
    • A stent is provided in combination with delivery of a tocopherol agent, and in particular a des-methyl tocopherol agent, and further beneficially a gamma-tocopherol agent, so as to reduce restenosis along the vessel or other lumenal wall where the stent is implanted. In particular applications, the stent is an endolumenal stent, and more specific beneficial applications is an endovascular stent, and the gamma-tocopherol elutes from a coating or carrier coupled with the stent. Certain combinations are provided with the des-methyl-tocopherol or phytyl substituted chromanol, e.g. gamma-tocopherol, combined with an additional agent such as an anti-restenosis agent, e.g. sirolimus, tacrolimus, everolimus, or paclitaxel, in order to provide synergistic benefit to tissues along the stented or recanalized regions. Other forms of tocopherol or tocotrienol, or other phytyl substituted chromanols, and other compounds such as palm oil, are also contemplated, for use to treat restenosis.
    • 提供支架与生育酚试剂,特别是脱甲基生育酚试剂的输送结合,进一步有益地提供γ-生育酚试剂,以便沿植入支架的血管或其它内腔壁减少再狭窄。 在具体应用中,支架是腔内支架,更具体的有益应用是血管内支架,并且γ-生育酚从与支架耦合的涂层或载体洗脱。 提供了去甲基 - 生育酚或植酰取代的色原烷醇的某些组合,例如。 γ-生育酚与另外的药物如抗再狭窄剂组合,如抗再狭窄剂。 西罗莫司,他克莫司,依维莫司或紫杉醇,以便为沿着支架或再通的区域的组织提供协同的益处。 还考虑了其​​它形式的生育酚或生育三烯酚或其它植烷基取代的色原醇,以及其它化合物如棕榈油,用于治疗再狭窄。